首页 | 本学科首页   官方微博 | 高级检索  
     

仙茅苔黑酚龙胆二糖苷调控NF-κB/Nrf2通路抑制破骨细胞氧化应激及其骨吸收的研究
引用本文:李鹤鸣,刘梦琴,虞艳玮,沈燚,杜金蔓,胡思婧,徐金龙,张泉龙,秦路平,张巧艳. 仙茅苔黑酚龙胆二糖苷调控NF-κB/Nrf2通路抑制破骨细胞氧化应激及其骨吸收的研究[J]. 中草药, 2024, 55(3): 822-831
作者姓名:李鹤鸣  刘梦琴  虞艳玮  沈燚  杜金蔓  胡思婧  徐金龙  张泉龙  秦路平  张巧艳
作者单位:浙江中医药大学药学院, 浙江 杭州 310053;浙江中医药大学药学院, 浙江 杭州 310053;福建中医药大学药学院, 福建 福州 350108;中国人民解放军联勤保障部队第九六九医院, 内蒙古自治区 呼和浩特 010051
基金项目:国家自然科学基金资助项目(81973534);国家自然科学基金资助项目(82374003)
摘    要:目的 探讨仙茅苔黑酚龙胆二糖苷(orcinol gentiobioside,OGB)对氧化应激诱导的破骨细胞(osteoclasts,OCs)的作用及机制。方法 可溶性核因子-κB受体活化因子配体(soluble receptor activator of nuclear factor-κB ligand,sRANKL)联合H2O2诱导RAW264.7细胞,建立氧化应激诱导的OCs模型;CCK-8法检测OCs活力;抗酒石酸酸性磷酸酶(tartrate resistant acid phosphatase,TRAP)染色测定OCs的数目;磷酸苯二钠法测定OCs的TRAP活性;免疫荧光法观察OCs的Factin环结构和形态,以及p65和核因子E2相关因子2(nuclear factor erythroid 2-related factor 2,Nrf2)的核转位;ELISA法测定OCs相关的生化指标;Western blotting检测骨吸收关键蛋白及核因子-κB(nuclear factor-κB,NF-κB)和Nrf2通路相关蛋白的表达。结果 OGB显著抑制氧化应激诱导的OCs的形成和...

关 键 词:仙茅  苔黑酚龙胆二糖苷  破骨细胞  氧化应激  核因子-κB通路  核因子E2相关因子2通路
收稿时间:2023-09-05

Orcinol gentiobioside from Curculigo orchioides inhibits oxidative stress and bone resorption in osteoclasts by regulation of NF-κB and Nrf2 pathways
LI Heming,LIU Mengqin,YU Yanwei,SHEN Yi,DU Jinman,HU Sijing,XU Jinlong,ZHANG Quanlong,QIN Luping,ZHANG Qiaoyan. Orcinol gentiobioside from Curculigo orchioides inhibits oxidative stress and bone resorption in osteoclasts by regulation of NF-κB and Nrf2 pathways[J]. Chinese Traditional and Herbal Drugs, 2024, 55(3): 822-831
Authors:LI Heming  LIU Mengqin  YU Yanwei  SHEN Yi  DU Jinman  HU Sijing  XU Jinlong  ZHANG Quanlong  QIN Luping  ZHANG Qiaoyan
Affiliation:School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China;School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China;College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China;969 Hospital of PLA Joint Logistics Support Forces, Hohhot 010051, China
Abstract:Objective To investigate the effect and mechanism of orcinol gentiobioside (OGB) from Curculigo orchioides on osteoclasts (OCs) induced by oxidative stress. Methods OCs model were established from RAW264.7 cells induced by soluble receptor activator of nuclear factor-κB ligand (sRANKL) and H2O2. The viability of OCs was assayed by CCK-8 method. The number of OCs was determined by tartrate-resistant acid phosphatase (TRAP) staining. TRAP activity of OCs was detected by using p-PNPP-Na method. F-actin and nuclear translocation of p65 and nuclear factor erythroid 2-related factor 2 (Nrf2) were stained with immunofluorescence method. The biochemical parameters of OCs were detected by ELISA. The expressions of key proteins involved in bone resorption and nuclear factor-κB (NF-κB)/Nrf2 pathway were analyzed by Western blotting. Results OGB significantly inhibited the formation and differentiation of OCs (P < 0.01), and significantly suppressed TRAP activity, formation of F-actin and bone resorption of OCs (P < 0.05, 0.01), down-regulated the expressions of c-Fos, cathepsin K (CTSK) and matrix metallopeptidase 9 (MMP9) (P < 0.05, 0.01), reduced the levels of reactive oxygen species (ROS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) activity (P < 0.05, 0.01), improved the activities of heme oxygenase-1 (HO-1), quinone oxidoreductase 1 (NQO1) and gamma-glutamyl cysteine synthetase (γ-GCS) (P < 0.05, 0.01). In addition, OGB also enhanced the expression and nucleus translocation of Nrf2 in OCs, inhibited the recruitment of tumor necrosis factor receptor-associated factor 6 (TRAF6), the degradation of inhibitor of NF-κB-α (IκBα) and prevented the phosphorylation and nuclear translocation of p65 in OCs (P < 0.05). Conclusion OGB inhibits formation, differentiation and bone resorption of OCs induced by oxidative stress through regulation of NF-κB and Nrf2 pathways.
Keywords:Curculigo orchioides Gaertn.  orcinol gentiobioside  osteoclasts  oxidative stress  nuclear factor-κB pathway  nuclear factor erythroid 2-related factor 2 pathway
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号